| Trial ID: | L0488 |
| Source ID: | NCT06381076
|
| Associated Drug: |
Liposomal Curcumin
|
| Title: |
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease 5D
|
| Interventions: |
DRUG: Liposomal curcumin|DRUG: Food colorant
|
| Outcome Measures: |
Primary: high-sensitivity C-reactive protein, baseline to end line in the concentration of high-sensitivity C-reactive protein between the control and intervention group., 12 weeks or 84 days | Secondary: Advanced glycation end products, baseline to end line in the concentration of advanced glycation end products between the control and intervention group., 12 weeks or 84 days|fatty acid byproduct - 4-hydroxynon-enal, baseline to end line in the concentration of fatty acid byproduct - 4-hydroxynon-enal between the control and intervention group., 12 weeks or 84 days|fatty acid byproduct - malondialdehyde, baseline to end line in the concentration of fatty acid byproduct - malondialdehyde between the control and intervention group., 12 weeks or 84 days|fatty acid byproduct - 8-F2 isoprostanes, baseline to end line in the concentration of fatty acid byproduct - 8-F2 isoprostanes between the control and intervention group., 12 weeks or 84 days|Klotho, baseline to end line in the concentration of klotho between the control and intervention group., 12 weeks or 84 days
|
| Sponsor/Collaborators: |
Sponsor: University of Florida
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2025-02-03
|
| Completion Date: |
2025-12
|
| Results First Posted: |
|
| Last Update Posted: |
2025-02-10
|
| Locations: |
University of Florida, Gainesville, Florida, 32611, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT06381076
|
